Additionally, genetic mutations, for example in the peroxisome proliferator-activated receptor gamma (PPARγ) gene, may play a role in the development of insulin resistance by leading to altered insulin levels, molecular signaling and lipid metabolism. The gene discussed is PPARG; the disease is Insulin resistance.